Care for pregnancy and delivery of HIV-positive women;Betreuung HIV-positiver frauen in der schwangerschaft und unter der geburt

Gynakologe

Volumn 38, Issue 8, 2005, Pages 688-693

  Gingelmaier, A ^a   Friese, K ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Delivery; HIV infection; Pregnancy; Vertical transmission

Indexed keywords

CLINICAL PRACTICE; DELIVERY; GYNECOLOGY; HEALTH CARE ACCESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MEDICAL SPECIALIST; PATIENT CARE; PREGNANCY; PROGNOSIS; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; TEAMWORK; VERTICAL TRANSMISSION;

EID: 24344444144     PISSN: 00175994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00129-005-1724-y     Document Type: Review

References (25)

1. Kind C, Rudin C, Siegrist C et al. (1998) Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. AIDS 12: 205-210
2. Hollwitz B, Gingelmaier A, Gröger S et al. (2004) Course of pregnancy and fetal outcome of 597 HIV-exposed pregnancies in german reference centers 1999-2003. World AIDS Conference, Bangkok, Poster ThPeB7119
3. European Group CS (1991) Children born to women with HIV-1 infection: natural history and risk of vertical transmission. Lancet 337: 253-260
4. Center of Disease Control and Prevention (1993) Technical guidance on HIV counseling. MMWR Morb Mortal Wkly Rep 42: 11-17
5. Connor EM, Sperling RS, Gelber R et al. (1994) Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 331: 1173-1180
6. The International Perinatal HIV Group (1999) The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 - A metaanalysis of 15 prospective cohort studies. N Engl J Med 340: 977-987
7. Schäfer A, Friese K, Grosch-Wörner I, Lauper U, Hebisch G, Hugger C (1999) Primäre Kaiserschnittent-bindung mit und ohne antiretrovirale Prophylaxe und Prävention der materno-fetalen Transmission von HIV-1. Bundesgesundheitsblatt 7: 569-576
8. Robert-Koch-Instituts (2004) Epidemiologisches Bulletin Nr. 47
9. Graves N, Walker DG, McDonald AM, Kaldor JM, Ziegler JB (2004) Would universal antenatal screening for HIV infection be cost-effective in a setting of very low prevalence? Modelling the data for Australia. J Inf Dis 190: 166-174
10. Bramley D, Graves N, Walker DG (2003) The cost-effectiveness of universal antenatal screening for HIV in New Zealand. AIDS 17: 741-748
11. Rouzioux C, Costagliola D, Burgard M et al. (1995) Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. The HIV Infection in Newborn French Collaborative Study Group. Am J Epidemiol 142: 1330-1337
12. Buchholz B, Beichert M, Marcus U, Grubert T, Gingelmaier A, Brockmeyer NH, Deutsche AIDS-Gesellschaft (DAIG), Österreichische AIDS-Gesellschaft (ÖAG), Robert Koch Institut et al. (2003) Deutsch-Österreichische Empfehlungen zur HIV-Therapie in der Schwangerschaft.http://www.rki.de/cln_011/ nn_334606/DE/Content/InfAZ/H/HIVAIDS/Therapie/Leitlinien/D_A_schwanger.html
13. Shapiro D, Tuomala R, Samelson R et al. (2002). Abstract 12953, 9th Conference on Retroviruses and Opportunistic Infections, Seattle
14. European Collaborative Study (2005) Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 40: 458-465
15. Nduati R, John G, Mbori-Ngacha D, Richardson BA et al. (2000) Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 283: 1167-1174
16. Nduati RW, John GC, Richardson BA et al. (1995). Human immunodeficiency virus type 1 infected cells in breast milk. J Infect Dis 172: 1461-1468
17. World Health Organization (2001) New data on the prevention of mother-to-child transmission of HIV and their policy implications: conclusions and recommendations. WHO, Geneva, Report No. WHO/RHR/01.28
18. World Health Assembly (2001) Infant and young child nutrition. Geneva, Resolution WHA54.2
19. Goldenberg RL, Vermund SH, Goepfert AR, Andrews WW (1998) Choriodecidual inflammation: a potentially preventable cause for perinatal HIV-1 transmission. Lancet 352: 1927-1930
20. Nicolaides KH, Sebire NJ, Snijders JM (2000). Die Ultraschalluntersuchung der 11.-14 Schwangerschaftswoche. Diagnostik fetaler Fehlbildungen. Parthenon, New York London
21. Maiques V, Garcia-Tejedor A, Perales A, Cordoba J, Esteban RJ (2003) HIV detection in amniotic fluid samples. Amniocentesis can be performed in HIV pregnant women? Eur J Obstet Gynecol Reprod Biol 108: 137-141
22. Stratton P, Gupta P, Riester K et al. (1999) Cervical dysplasia on cervicovaginal Papanicolaou smear among HIV-1-infected pregnant and nonpregnant women. Women and Infants Transmission Study. J Acquir Immune Defic Syndr Hum Retrovirol 20: 300-307
23. Thorne C, Patel D, Newell ML (2004) Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe. AIDS 18: 2337-2339
24. The International Perinatal HIV Group (2001) Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies. AIDS 15: 357-368
25. Friese K, Schäfer, A, Hof H (Hrsg) (2002) Infektions-krankheiten in der Gynäkologie und Geburtshilfe. Springer, Berlin Heidelberg New York Tokio